Protein kinase C has been implicated in the mechanism of action of some hormones. Phorbol esters are known to activate this enzyme, but although short-term exposure t o such compounds causes activation, prolonged exposure can reduce both the amount and the activity of the enzyme to low levels (Ballester & Rosen, 1985) . A number of investigators have used such down-regulation of protein kinase C to investigate its role in the actions of hormones and regulation of hormone secretion (Hii et al., 1987; Smal & De Meyts, 1987; Ohmura et al., 1988) . We have used down-regulation by the phorbol ester, tetradecanoyl phorbol acetate (TPA) to investigate the role of protein kinase C in the actions of growth hormone releasing hormone (GHRH), thyrotrophin releasing hormone (TRH), dopamine and somatostatin on growth hormone (GH) and prolactin secretion in cultured ovine anterior pituitary cells.
Cells from ovine anterior pituitary glands were dispersed and placed in short-term culture for 3-4 days as described by Ray & Wallis (1982) . Before use in experiments. they were washed with serum-free medium and then incubated in fresh serum-free medium containing test materials, as indicated, for 30 min. GH and prolactin secreted into the medium and intracellular cyclic AMP concentrations were measured by radioimmunoassay as described previously (Ray & Wallis, 1982) .
TPA (100 ng/ml) stimulated secretion of GH and prolactin from cultured ovine anterior pituitary cells, as shown previously (Ray et ul.. 1986) . Pretreatment of the cells with TPA (0.1-1000 ng/ml) for 5 h resulted in a dose-dependent attenuation of this stimulatory effect on both prolactin and G H release. Pretreatment with 1 pg of TPA/ml completely abolished the stimulatory effect of 100 ng of TPA/ml on release of these hormones, indicating complete down-regulation of protein kinase C.
Pretreatment of ovine anterior pituitary cells with 1 p u g of TPA/ml for 5 h had no significant effect on the ability of TRH (100 nM) to stimulate prolactin release. The ability of dopamine (100 n M ) to inhibit TRH-stimulated prolactin release was also not significantly affected by the TPA pretreatment. TPA pretreatment ( 5 h) did attenuate the stimulatory effect of GHRH ( 1 nM) on GH release (44 k 5%). The ability of somatostatin (100 nM) to inhibit GHRH-stimulated GH release was also partially blocked by the TPA pretrcatment. The ability of 10 pM-forskohn to stimulate GH release was similarly blocked, as was the inhibitory effect of somatostatin on forskolin-stimulated GH release.
Abbreviations used: TPA, tetradecanoyl phorbol acetate; GHRH. growth hormone releasing hormone: TRH. thyrotrophin releasing hormone; GH, growth hormone.
The cellular content of GH was markedly depleted by the TPA pretreatment (78 f 7%), whereas the content of prolactin was only slightly depleted (23 f 5%). The cellular cyclic AMP content was markedly increased by GHRH, as expected, and this increase was not attenuated by TPApretreatment.
Although protein kinase C may play a role in the actions of TRH on secretion of prolactin from rat pituitary tumourderived cells (GH cells), little evidence supports such a role for actions of TRH on normal lactotrophs, although it may be important for negative feedback regulation (Judd et ul.. 1087) . Failure of down-regulation of protein kinase C to interfere with the action of TRH. as shown here, accords with a minimal role for protein kinase C in the actions of the hormone. Similarly, lack of effect of TPA pretreatment on inhibition of prolactin secretion by dopamine suggests that for this factor too protein kinase does not play a major part in the mechanism of action. Pretreatment of cells with TPA did partially block the actions of both GHRH and somatostatin on GH secretion. This could indicate that protein kinase C plays a part in the mechanism of action of these factors, but other explanations are possible. Depletion of cellular content of GH by TPA pretreatment was considerable, and this could explain the subsequent decrease in responsiveness to GHRH, though it would not explain the changes in cyclic AMP levels in response to GHRH, nor the partial blocking of inhibitory actions of somatostatin. Phosphorylation of receptors or associated proteins by protein kinase C during the pretreatment period (which presumably involves an activation of the enzyme before depletion) could also lead to decreased responsiveness/desensitization. Previous studies have also suggested a role for protein kinase C in the actions of GHRH (Cronin et ul., 1985; Ohmura et ul., 1988) , but it must be concluded that such a role is not yet firmly established.
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